Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Hoosier Cancer Research Network
With
OUTLINE: This is a multi-center study. * Dexamethasone and antiemetic premedication1. * Docetaxel: 60 mg/m2 for a 60 minute infusion day 1 of each cycle * Capecitabine: 825 mg/m2 po BID Days 1-14 Repeat every 21 days until tumor progression or toxicity that requires discontinuation of therapy Performance status: ECOG performance status 0 or 1 Life expectancy: At least 3 months Hematopoietic: * ANC of \> 1,500/mm3 * Platelets \> 100,000/mm3 * Hemoglobin \> 8 gm/dl Hepatic: * Total Bilirubin £ ULN * Albumin \> 3 * Maximum Alk Phos \> 2.5 x \< 5 x ULN Renal: * Creatinine clearance of \> 50 ml/ min (by Cockcroft-Gault) Cardiovascular: * No decompensated congestive heart failure or active angina. * Clinically significant cardiac disease not well controlled with medication (eg. congestive heart failure, symptomatic coronary artery disease and cardiac arrhythmias) or myocardial infarction in the past 12 months is not allowed. Pulmonary: * Not specified
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
